foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI FOXO4/p53 Peptide – Peptagon
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21




















:max_bytes(150000):strip_icc()/GettyImages-2246015697-1f1c65229d9d47fbb5df86e120ce93fc.jpg)







